J Neurol Surg A Cent Eur Neurosurg 2015; 76(05): 341-347
DOI: 10.1055/s-0034-1543959
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Will an Asymptomatic Meningioma Grow or Not Grow? A Meta-analysis

Lingcheng Zeng
1   Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China
,
Pei Liang
2   Sensory Science Laboratory, School of Bioscience and Food Engineering, Changshu Institute of Technology, China
,
Jiantong Jiao
1   Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China
,
Jian Chen
1   Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China
,
Ting Lei
1   Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China
› Author Affiliations
Further Information

Publication History

06 May 2014

24 October 2014

Publication Date:
23 March 2015 (online)

Abstract

Background The treatment strategy for patients with an asymptomatic meningioma is still controversial. Key to an optimal decision is a careful evaluation of the growth possibilities of the meningioma by taking the patient's clinicoradiologic factors into consideration. However, previous studies have disagreed about the risk factors relating to tumor growth.

Methods A comprehensive search of PubMed, Embase, and the ISI Web of Knowledge was performed. Using a meta-analysis with nine subsidiary studies including 777 patients, we analyzed the correlation of the growth pattern of meningioma with patient gender, tumor location, tumor calcification, magnetic resonance imaging (MRI) T2 signal intensity, and peritumoral brain edema.

Results The growth rate of meningioma was negatively correlated with tumor calcification (odds ratio [OR]: 0.23; 95% confidence interval (CI), 0.11–0.46; p < 0.001) but positively associated with MRI T2 signal intensity (OR: 2.75; 95% CI, 1.75–4.33; p < 0.001). No correlations were found between tumor growth and other factors such as gender (OR: 1.29; 95% CI, 0.84–1.99; p = 0.24), skull base location (OR: 0.80; 95% CI, 0.25–2.58; p = 0.70), and peritumoral brain edema (OR: 1.24; 95% CI, 0.29–5.27; p = 0.77).

Conclusions Two factors, tumor calcification and low MRI T2 signal intensity, indicate the possibility of a slow growth meningioma. In such cases of asymptomatic meningioma, a follow-up strategy can be preferentially considered.

 
  • References

  • 1 Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet 2004; 363 (9420) 1535-1543
  • 2 Chamoun R, Krisht KM, Couldwell WT. Incidental meningiomas. Neurosurg Focus 2011; 31 (6) E19
  • 3 Go RS, Taylor BV, Kimmel DW. The natural history of asymptomatic meningiomas in Olmsted County, Minnesota. Neurology 1998; 51 (6) 1718-1720
  • 4 Yano S, Kuratsu J ; Kumamoto Brain Tumor Research Group. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 2006; 105 (4) 538-543
  • 5 Firsching RP, Fischer A, Peters R, Thun F, Klug N. Growth rate of incidental meningiomas. J Neurosurg 1990; 73 (4) 545-547
  • 6 Braunstein JB, Vick NA. Meningiomas: the decision not to operate. Neurology 1997; 48 (5) 1459-1462
  • 7 Staneczek W, Jänisch W. Epidemiologic data on meningiomas in East Germany 1961–1986: incidence, localization, age and sex distribution. Clin Neuropathol 1992; 11 (3) 135-141
  • 8 Hashimoto N, Rabo CS, Okita Y , et al. Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. J Neurosurg 2012; 116 (3) 574-580
  • 9 Rubin G, Herscovici Z, Laviv Y, Jackson S, Rappaport ZH. Outcome of untreated meningiomas. Isr Med Assoc J 2011; 13 (3) 157-160
  • 10 Oya S, Kim SH, Sade B, Lee JH. The natural history of intracranial meningiomas. J Neurosurg 2011; 114 (5) 1250-1256
  • 11 Pravdenkova S, Al-Mefty O, Sawyer J, Husain M. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg 2006; 105 (2) 163-173
  • 12 Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T. Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev 2006; 29 (4) 293-296 ; discussion 296–297
  • 13 Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J. Meningioma: proliferating potential and clinicoradiological features. Neurosurgery 1995; 37 (6) 1049-1055
  • 14 Hashiba T, Hashimoto N, Maruno M , et al. Scoring radiologic characteristics to predict proliferative potential in meningiomas. Brain Tumor Pathol 2006; 23 (1) 49-54
  • 15 Hashiba T, Hashimoto N, Izumoto S , et al. Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg 2009; 110 (4) 675-684
  • 16 Di Maio S, Ramanathan D, Garcia-Lopez R , et al. Evolution and future of skull base surgery: the paradigm of skull base meningiomas. World Neurosurg 2012; 78 (3–4) 260-275
  • 17 Kizana E, Lee R, Young N, Dorsch NW, Soo YS. A review of the radiological features of intracranial meningiomas. Australas Radiol 1996; 40 (4) 454-462
  • 18 Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J. Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 2000; 68 (1) 25-28
  • 19 Kuratsu J, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 2000; 92 (5) 766-770
  • 20 Sitthinamsuwan B, Khampalikit I, Nunta-aree S, Srirabheebhat P, Witthiwej T, Nitising A. Predictors of meningioma consistency: a study in 243 consecutive cases. Acta Neurochir (Wien) 2012; 154 (8) 1383-1389
  • 21 Tenner MS, Spiller M, Koenig SH , et al. Calcification can shorten T2, but not T1, at magnetic resonance imaging fields. Results of a relaxometry study of calcified human meningiomas. Invest Radiol 1995; 30 (6) 345-353
  • 22 Lobato RD, Alday R, Gómez PA , et al. Brain oedema in patients with intracranial meningioma. Correlation between clinical, radiological, and histological factors and the presence and intensity of oedema. Acta Neurochir (Wien) 1996; 138 (5) 485-493 ; discussion 493–494
  • 23 Vignes JR, Sesay M, Rezajooi K, Gimbert E, Liguoro D. Peritumoral edema and prognosis in intracranial meningioma surgery. J Clin Neurosci 2008; 15 (7) 764-768
  • 24 Nakano T, Asano K, Miura H, Itoh S, Suzuki S. Meningiomas with brain edema: radiological characteristics on MRI and review of the literature. Clin Imaging 2002; 26 (4) 243-249
  • 25 Oya S, Sade B, Lee JH. Benefits and limitations of diameter measurement in the conservative management of meningiomas. Surg Neurol Int 2011; 2: 158
  • 26 Yoneoka Y, Fujii Y, Tanaka R. Growth of incidental meningiomas. Acta Neurochir (Wien) 2000; 142 (5) 507-511
  • 27 Couldwell WT. Asymptomatic meningiomas. J Neurosurg 2006; 105 (4) 536-537 ; discussion 537
  • 28 Nakamura M, Roser F, Michel J, Jacobs C, Samii M. The natural history of incidental meningiomas. Neurosurgery 2003; 53 (1) 62-70 ; discussion 70–71
  • 29 Olivero WC, Lister JR, Elwood PW. The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 1995; 83 (2) 222-224
  • 30 Herscovici Z, Rappaport Z, Sulkes J, Danaila L, Rubin G. Natural history of conservatively treated meningiomas. Neurology 2004; 63 (6) 1133-1134